PA
LNW

PharVision Advisers’s Light & Wonder LNW Stock Holding History

PharVision Advisers’s Portfolio LNW Stock Details LNW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,571
Closed -$247K – 735
2025
Q2 		$247K Buy
+2,571
New +$220K 0.36% 141

Other funds holding LNW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCP
Fine Capital Partners New York $563M AUM 7.48% 1-Year Est. Return
CPIH
Consolidated Press International Holdings Sydney, Australia $631K AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
CIA
Caledonia Investments (Australia) Sydney NSW, Australia $3.44B AUM 20.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAM
Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return

PharVision Advisers's LNW Position: Q3 2025 in Review

PharVision Advisers sold out of Light & Wonder (LNW) in Q3 2025, closing a stake of 2,571 shares — an estimated $247K sold.

PharVision Advisers first reported a position in LNW in Q2 2025 and held it in 1 quarter. The position peaked at $247K in Q2 2025. 288 funds tracked by Wall St. Rank hold LNW as of Q3 2025.

  • PharVision Advisers reported no remaining Light & Wonder position as of Q3 2025 after selling out during the quarter.
  • PharVision Advisers sold 2,571 Light & Wonder shares in Q3 2025, an estimated $247K.
  • PharVision Advisers first reported a position in Light & Wonder in Q2 2025 and held it in 1 quarter.
  • PharVision Advisers's Light & Wonder position peaked at $247K in Q2 2025.
  • 288 funds tracked by Wall St. Rank held Light & Wonder as of Q3 2025.

Based on PharVision Advisers's 13F filing for Q3 2025, filed 17 Nov 2025.